je.st
news
Elan to return $1Billion to shareholders
2013-02-22 10:04:55| Biotech - Topix.net
Irish drugmaker Elan will return $1 billion to shareholders and seek acquisitions with the proceeds of selling its stake in blockbuster multiple sclerosis treatment Tysabri to partner Biogen Idec.
Tags: return
shareholders
elan
1billion
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||